Literature DB >> 19577484

Rationale for propofol use in cardiac surgery.

Lukasz J Krzych1, Dariusz Szurlej, Andrzej Bochenek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19577484     DOI： 10.1053/j.jvca.2009.05.001

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  4 in total

1.  Cardiogenic shock following administration of propofol and fentanyl in a healthy woman: a case report.

Authors:  Alfredo Renilla González; Iñigo Lozano Martinez-Luengas; Sandra Secades González; Irene Alvarez Pichel; Paloma Alvarez Martinez; Elena Santamarta Liébana; Beatriz Díaz Molina
Journal:  J Med Case Rep       Date:  2011-08-16

2.  Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions.

Authors:  Ali Dabbagh; Samira Rajaei; Ayad Bahadori Monfared; Ali Asghar Keramatinia; Korosh Omidi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

3.  Additive effect of propofol and fentanyl precipitating cardiogenic shock.

Authors:  Ac Jesudoss Prabhakaran
Journal:  J Pharmacol Pharmacother       Date:  2013-07

4.  Cardioprotective effects of propofol-dexmedetomidine in open-heart surgery: A prospective double-blind study.

Authors:  Ahmed Said Elgebaly; Sameh Mohamad Fathy; Ayman Ahmed Sallam; Yaser Elbarbary
Journal:  Ann Card Anaesth       Date:  2020 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.